The Gemigliptin Market has been witnessing significant growth in recent years, driven by the rising prevalence of diabetes and the increasing demand for effective treatment options. Gemigliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is used for the management of type 2 diabetes mellitus.
The global gemigliptin market size was valued at US$ 1.79 Bn in 2024 and is...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian